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Background: Fully biodegradable stent is an attractive alternative strategy for current permanent metallic stents. We evaluated a novel, fully 
bioabsorbable sirolimus-eluting stent (8.3μg sirolimus/mm stent) synthesized entirely from salicylic-acid polymer in a animal model.
Methods: Bioabsorbable balloon-expandable stents (n=33) were implanted in pig coronaries using QCA to optimize stent apposition. Animals 
underwent restudy and terminated at 1M, 3M, 6M, 9M and 12M. Thickness and area of each strut (implantation: 1273 struts, 1M: 640 struts, 3M: 
585 struts, 6M: 625 struts, 9M: 530 struts, 12M: 319struts) were measured. And Intensity of each strut was also measured.
Results: Average strut thickness and area at 1M was similar to post implantation (implant: 0.25mm, 0.14mm2, 1M: 0.26mm, 0.12mm2). Strut 
Thickness and area gradually decreased over time (3M: 0.23mm and 0.09mm2; 6M: 0.186mm and 0.07mm2, 9M: 0.179mm and 0.066mm2, 
12M: 0.158mm and 0.055mm2, respectively, P<0.0001) On the other hands, once OCT signal intensity gradually become lower from 1M to 3M 
(1M: 6.06W, 3M; 5.92W, P<0.001), then gradually become higher from 3M to 6 M and again (6M: 6.16W, P<0.001). But there are no significantly 
difference between 6M, 9M and 12M (P=0.51, P=0.31)
Conclusions: Degradation of a novel fully bioabsorbable salicylate-based stent was demonstrated by OCT. The size of this stent was remarkably 
decreased from 1M to 3M, 6M, 9M and 12M. But remarkable change about intensity was not observed from 6M to 9M and 12M.
